Background: Nodular hidradenocarcinoma was first reported as clear-cell eccrine carcinoma by Keasby and Hadley in 1954 (Cancer 1954;7:934-52) and rare malignant tumor. Several synonyms and related terms for nodular hidradenocarcinoma have appeared in the literature.
Objective: They have potential for uncontrollable local recurrence, tend to metastasize, and often cause death. Most cases have been reported in the pathology literature with limited clinical information.
Methods: We report a 27-year-old woman with nodular hidradenocarcinoma on the scalp.
Result: The management of rare cases is not well defined. In our case, she was only treated with a wide local excision, and no recurrence was observed 2 years after excision.
Conclusion: Most authors have concluded that early wide surgical excision of the tumor is the treatment of choice. The efficiency of adjuvant therapy generally has not established.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1524-4725.2004.30390.x | DOI Listing |
J Cutan Pathol
December 2024
Department of Dermatology, James A. Haley Veterans Hospital, Tampa, Florida, USA.
A 91-year-old man presented with a cutaneous left abdominal mass. The mass was longstanding (over 5 years) and slow-growing. Examination revealed a violaceous, multinodular, and exophytic non-tender mass surrounded by patchy erythema.
View Article and Find Full Text PDFAm J Surg Pathol
August 2023
Department of Pathology and Laboratory Medicine, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.
Hidradenocarcinomas are rare cutaneous adnexal malignancies with sweat gland differentiation that can show a broad spectrum of histomorphologic appearances, ranging from low to high grade. The diagnosis of low-grade hidradenocarcinoma can be challenging and may be mistaken for benign hidradenomas, especially on superficial and partial samples. We performed a retrospective analysis of 16 low-grade hidradenocarcinomas, obtained from 4 large academic institutions.
View Article and Find Full Text PDFCureus
April 2023
Radiation Oncology, Instituto Português de Oncologia do Porto, Porto, PRT.
Hidradenocarcinoma, a rare malignant entity that derives from sweat glands, is especially rare in the pediatric population. The treatment of choice is surgery. Radiation therapy is used only in selected patients.
View Article and Find Full Text PDFCureus
December 2022
Department of Otolaryngology and Pediatrics, Thomas Jefferson University Sidney Kimmel School of Medicine, Philadelphia, USA.
The objective of this study was to discuss an unusual postauricular mass in a pediatric patient. This mass had a broad differential including congenital anomaly, neoplasm, infection, and lymphovascular malformation. Atypical nodular hidradenoma is a rare adnexal tumor that is difficult to differentiate from hidradenocarcinoma.
View Article and Find Full Text PDFInt J Surg Case Rep
December 2022
Department of General Surgery, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Introduction: Hidradenocarcinoma is an uncommon slow-growing malignant tumor that originates from sweat glands, it is most seen in the head and neck, and present typically as hard asymptomatic nodule. Diagnosis is confirmed by histopathology and immunohistochemistry, and wide local excision is the mainstay of the treatment. In our study, we discuss the approach and management of this rare disease, with focusing on the importance of histopathology in diagnosing such cases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!